Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes

NCT05834868 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1040

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: THDB0206 Injection
DRUG: Insulin Lispro Injection

Sponsor

Tonghua Dongbao Pharmaceutical Co.,Ltd